Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
| Class:Id | Person:9924918 |
|---|---|
| _displayName | Shen, Shourong |
| _timestamp | 2024-10-16 18:47:29 |
| created | [InstanceEdit:9925315] Tiwari, Krishna, 2024-10-16 |
| firstname | Shourong |
| initial | S |
| modified | [InstanceEdit:9925426] Tiwari, Krishna, 2024-10-16 |
| surname | Shen |
| (author) | [LiteratureReference:9925136] The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer [LiteratureReference:9925281] MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma |
| [Change default viewing format] | |